ArticleOncoimmunology2013

HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients.

Hans-Henning Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.